SleepQ 2.0: 필과 AI의 융합

Chronic insomnia patients rely on medication but face tolerance and side effect issues, while cognitive behavioral therapy for insomnia (CBT-i) is effective but time-consuming. Conducting drug and non-drug treatments separately makes mutual complementation difficult.

SleepQ 2.0 uses AI to analyze patient data (sleep patterns, medication times, etc.) to customize and control optimal medication times and sleep environment (lighting, sound).

For example, it automatically creates an environment that maximizes drug effects by dimming the room lights and blocking blue light from the phone in advance when the sleeping pill takes effect. In addition, AI monitors user behavior during the day (whether they take a nap, caffeine intake, etc.) and induces behavioral changes with notifications when necessary. This is innovative in that it merges drug treatment and digital treatment, rather than running them in parallel, and AI provides the best collaborative treatment for each individual.

Hospitals and sleep clinics (B2B) can provide it as a prescription to insomnia patients, or individual patients (B2C) can use the app/service under the guidance of a doctor.

As the digital therapeutics market grows, drug + digital hybrid treatment models may receive attention. WELT already has digital health experience with smart belts, etc., increasing reliability. If regulatory approval (digital therapeutic device) is obtained, global expansion is possible, but acceptance by the medical community is key.

Introduced at CES with the expression "Medicine meets app," it was positively evaluated as a new treatment paradigm. However, the lack of specific clinical evidence was pointed out, and the need to prove actual effectiveness and secure the trust of doctors was noted. It is viewed as an R&D stage innovation in a broad sense.